Holen Sie sich die Stockscreener-App
4.47
4.49%
-0.21
Handel nachbörslich:
4.47
Schlusskurs vom Vortag:
$4.68
Offen:
$4.75
24-Stunden-Volumen:
7.72M
Relative Volume:
1.33
Marktkapitalisierung:
$793.31M
Einnahmen:
$2.54B
Nettoeinkommen (Verlust:
$-207.36M
KGV:
-3.7563
EPS:
-1.19
Netto-Cashflow:
$151.25M
1W Leistung:
-5.50%
1M Leistung:
-38.34%
6M Leistung:
-34.93%
1J Leistung:
-64.38%
1-Tages-Spanne:
$4.40
$4.77
1-Wochen-Bereich:
$4.40
$5.075
52-Wochen-Spanne:
$4.40
$15.21
Teladoc Health Inc Stock (TDOC) Company Profile
Firmenname
Teladoc Health Inc
Sektor
Branche
Telefon
(203) 635-2002
Adresse
155 E 44TH STREET, NEW YORK, NY
Compare TDOC vs VEEV, TEM, BTSG, HQY, DOCS
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
TDOC
Teladoc Health Inc
|
4.47 | 830.58M | 2.54B | -207.36M | 151.25M | -1.19 |
|
VEEV
Veeva Systems Inc
|
171.99 | 29.10B | 3.08B | 860.33M | 1.35B | 5.1463 |
|
TEM
Tempus Ai Inc
|
50.78 | 9.54B | 803.32M | -709.10M | -212.68M | -7.8003 |
|
BTSG
Brightspring Health Services Inc
|
37.79 | 7.22B | 11.99B | 24.18M | 234.31M | 0.2956 |
|
HQY
Healthequity Inc
|
73.21 | 6.57B | 1.15B | 96.70M | -161.99M | 1.09 |
|
DOCS
Doximity Inc
|
24.71 | 4.80B | 550.17M | 201.35M | 232.07M | 1.00 |
Teladoc Health Inc Stock (TDOC) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-12-09 | Eingeleitet | Barclays | Equal Weight |
| 2025-11-13 | Eingeleitet | BMO Capital Markets | Market Perform |
| 2025-07-25 | Eingeleitet | Mizuho | Neutral |
| 2024-11-15 | Eingeleitet | Goldman | Buy |
| 2024-09-17 | Bestätigt | Jefferies | Hold |
| 2024-02-29 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2024-02-26 | Eingeleitet | Leerink Partners | Market Perform |
| 2024-01-17 | Herabstufung | DA Davidson | Buy → Neutral |
| 2024-01-03 | Eingeleitet | Barclays | Overweight |
| 2023-04-12 | Eingeleitet | Stephens | Equal-Weight |
| 2023-02-23 | Hochstufung | SVB Securities | Market Perform → Outperform |
| 2022-10-24 | Hochstufung | Guggenheim | Sell → Neutral |
| 2022-09-16 | Eingeleitet | KeyBanc Capital Markets | Sector Weight |
| 2022-09-07 | Eingeleitet | Truist | Hold |
| 2022-08-17 | Herabstufung | Guggenheim | Neutral → Sell |
| 2022-08-12 | Eingeleitet | DA Davidson | Buy |
| 2022-08-02 | Herabstufung | Berenberg | Buy → Hold |
| 2022-08-02 | Herabstufung | Cowen | Outperform → Market Perform |
| 2022-07-28 | Herabstufung | Goldman | Buy → Neutral |
| 2022-07-28 | Herabstufung | Needham | Buy → Hold |
| 2022-07-06 | Bestätigt | BofA Securities | Neutral |
| 2022-05-05 | Herabstufung | Argus | Buy → Hold |
| 2022-04-28 | Herabstufung | Citigroup | Buy → Neutral |
| 2022-04-28 | Herabstufung | Credit Suisse | Outperform → Neutral |
| 2022-04-28 | Herabstufung | Guggenheim | Buy → Neutral |
| 2022-04-28 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2022-04-28 | Herabstufung | SVB Leerink | Outperform → Mkt Perform |
| 2022-04-28 | Herabstufung | Wells Fargo | Overweight → Equal Weight |
| 2022-04-28 | Herabstufung | William Blair | Outperform → Mkt Perform |
| 2022-04-07 | Eingeleitet | Guggenheim | Buy |
| 2022-04-01 | Fortgesetzt | Credit Suisse | Outperform |
| 2022-03-03 | Hochstufung | Argus | Hold → Buy |
| 2022-02-23 | Bestätigt | BofA Securities | Neutral |
| 2022-02-23 | Bestätigt | Craig Hallum | Hold |
| 2022-02-23 | Bestätigt | Evercore ISI | In-line |
| 2022-02-23 | Bestätigt | Goldman | Buy |
| 2022-02-23 | Bestätigt | JP Morgan | Overweight |
| 2022-02-23 | Bestätigt | KeyBanc Capital Markets | Overweight |
| 2022-02-23 | Bestätigt | Needham | Buy |
| 2022-02-23 | Bestätigt | Oppenheimer | Outperform |
| 2022-02-23 | Bestätigt | Stifel | Hold |
| 2022-02-11 | Eingeleitet | Goldman | Buy |
| 2022-02-08 | Bestätigt | Piper Sandler | Overweight |
| 2021-12-02 | Fortgesetzt | Jefferies | Hold |
| 2021-11-22 | Herabstufung | BTIG Research | Buy → Neutral |
| 2021-10-28 | Bestätigt | Barclays | Equal Weight |
| 2021-10-28 | Bestätigt | BofA Securities | Neutral |
| 2021-10-28 | Bestätigt | Canaccord Genuity | Buy |
| 2021-10-28 | Bestätigt | Citigroup | Buy |
| 2021-10-28 | Bestätigt | Craig Hallum | Hold |
| 2021-10-28 | Bestätigt | Needham | Buy |
| 2021-10-28 | Bestätigt | Oppenheimer | Outperform |
| 2021-10-28 | Bestätigt | Piper Sandler | Overweight |
| 2021-10-28 | Bestätigt | UBS | Neutral |
| 2021-10-19 | Eingeleitet | Wells Fargo | Overweight |
| 2021-08-02 | Herabstufung | Argus | Buy → Hold |
| 2021-07-28 | Herabstufung | Deutsche Bank | Buy → Hold |
| 2021-05-28 | Eingeleitet | Robert W. Baird | Neutral |
| 2021-04-15 | Eingeleitet | Needham | Buy |
| 2021-01-07 | Eingeleitet | BTIG Research | Buy |
| 2020-12-22 | Eingeleitet | Evercore ISI | In-line |
| 2020-12-07 | Herabstufung | Stephens | Overweight → Equal-Weight |
| 2020-12-04 | Eingeleitet | Goldman | Neutral |
| 2020-11-13 | Hochstufung | Robert W. Baird | Neutral → Outperform |
| 2020-09-22 | Eingeleitet | DA Davidson | Buy |
| 2020-09-02 | Hochstufung | Berenberg | Hold → Buy |
| 2020-08-17 | Hochstufung | Credit Suisse | Neutral → Outperform |
| 2020-07-14 | Eingeleitet | Citigroup | Buy |
| 2020-07-13 | Eingeleitet | Argus | Buy |
| 2020-07-07 | Eingeleitet | Stephens | Overweight |
| 2020-04-30 | Bestätigt | KeyBanc Capital Markets | Overweight |
| 2020-04-13 | Eingeleitet | SVB Leerink | Outperform |
| 2020-03-31 | Herabstufung | Berenberg | Buy → Hold |
| 2020-03-25 | Herabstufung | Craig Hallum | Buy → Hold |
| 2020-03-16 | Hochstufung | KeyBanc Capital Markets | Sector Weight → Overweight |
| 2020-03-12 | Herabstufung | Robert W. Baird | Outperform → Neutral |
| 2020-02-28 | Herabstufung | KeyBanc Capital Markets | Overweight → Sector Weight |
| 2020-02-12 | Herabstufung | Wells Fargo | Overweight → Equal Weight |
| 2020-01-10 | Eingeleitet | UBS | Neutral |
| 2020-01-09 | Herabstufung | BofA/Merrill | Buy → Neutral |
Alle ansehen
Teladoc Health Inc Aktie (TDOC) Neueste Nachrichten
Teladoc Announces Retirement of Long-Serving Board Director - TipRanks
Hims & Hers Strengthens Integrated Personalized Digital Care Platform - The Globe and Mail
Here's Why I Still Wouldn't Touch Teladoc With a 10‑Foot Pole - Yahoo Finance
Teladoc Health expands virtual care access through HealthKey partnership - Traders Union
Teladoc Health (NYSE:TDOC) Sets New 12-Month LowHere's What Happened - MarketBeat
HIMS Dips 55.8% in 3 Months: Should You Still Hold the Stock or Sell? - Finviz
Telemedicine Market to Reach US$ 488.89 Billion by 2033 at 16.8% - openPR.com
Dow Update: Is Teladoc Health Inc. stock positioned for long term growthTrade Ideas & Short-Term High Return Strategies - mfd.ru
Teladoc (TDOC) Registers a Bigger Fall Than the Market: Important Facts to Note - Yahoo Finance Singapore
Digital Health Market to Reach US$ 1,907.21 Billion by 2033, - openPR.com
Online Doctor Consultation Market Set for Explosive Growth - openPR.com
Stock Market Today, Feb. 9: Hims & Hers Health Drops 16% on Novo Nordisk Lawsuit - The Motley Fool
Teladoc (TDOC) Sees Increased Bullish Activity in Options Market - GuruFocus
Allianz Asset Management GmbH Grows Holdings in Teladoc Health, Inc. $TDOC - MarketBeat
United States Telehealth Solutions Market to Grow at 32.1% CAGR - openPR.com
Teladoc (TDOC) Sees Surge in Bullish Option Activity - GuruFocus
Best Telemedicine and Telehealth Stocks for 2026 - The Motley Fool
Teladoc Health, Inc. $TDOC Shares Sold by Y Intercept Hong Kong Ltd - MarketBeat
Teladoc Health, Inc. (NYSE:TDOC) Given Average Rating of "Hold" by Analysts - MarketBeat
Can Teladoc Health Inc reach all time highs this year - baoquankhu1.vn
Teladoc Health drives confidence in hypertension care - Traders Union
Teladoc Health to Announce Fourth Quarter 2025 Financial Results - The Manila Times
Jim Cramer on Teladoc: "I Don't See Any Reason to Own It" - Finviz
Jim Cramer on Teladoc: “I Don’t See Any Reason to Own It” - Insider Monkey
Lacklustre Performance Is Driving Teladoc Health, Inc.'s (NYSE:TDOC) 28% Price Drop - 富途牛牛
Teladoc Health, Inc.'s (NYSE:TDOC) 28% Dip In Price Shows Sentiment Is Matching Revenues - simplywall.st
Teladoc Health, Inc. (TDOC) Investor Outlook: Is The 66% Upside Within Reach? - DirectorsTalk Interviews
The Truth About Teladoc Health Inc: Is TDOC’s Telehealth Empire Still Worth Your Money? - AD HOC NEWS
Teladoc (TDOC) Stock Sinks As Market Gains: What You Should Know - Yahoo Finance
Teladoc Health (NYSE:TDOC) Hits New 12-Month LowHere's Why - MarketBeat
Teladoc Health (TDOC) Is Down 13.9% After Medicare Tightens Telehealth CoverageWhat's Changed - Sahm
(TDOC) Price Dynamics and Execution-Aware Positioning - Stock Traders Daily
A Look At Teladoc Health’s Valuation As Medicare Telehealth Policy And Options Activity Drive Uncertainty - Sahm
What are Teladoc Health Inc.’s earnings expectationsJuly 2025 Volume & Low Drawdown Investment Strategies - mfd.ru
Chuck Divita on why 2026 is Teladoc’s ‘execution year’ - Healthcare Dive
Teladoc hits all-time low as a risky pattern points to a deeper dive - TradingView
Published on: 2026-01-29 14:18:31 - baoquankhu1.vn
Teleoncology Market to Reach US$ 15.03 Billion by 2032 at 15.7% - openPR.com
A Look At Teladoc Health (TDOC) Valuation As Medicare And BetterHelp Concerns Drive Volatility - Yahoo Finance
Once Medicare Stops Covering Telehealth Services, Will Teladoc Health Stock be in Trouble? - The Globe and Mail
Medicare Telehealth Uncertainty And BetterHelp Weakness Test Teladoc Valuation - Sahm
Is Teladoc Health (TDOC) A Potential Opportunity After Prolonged Share Price Weakness - Yahoo Finance
Teladoc (TDOC) Stock Falls Amid Market Uptick: What Investors Need to Know - sharewise.com
Why Teladoc (TDOC) Shares Are Plunging Today - Finviz
Teladoc Health (NYSE:TDOC) Hits New 1-Year LowShould You Sell? - MarketBeat
Are Telehealth Stocks Set to Tumble in 2026? - The Globe and Mail
Teladoc stock hits 52-week low at 6.03 USD - Investing.com
Teladoc price target lowered to $7 from $7.50 at BofA Securities - Investing.com Canada
Teladoc (TDOC) Sees Surge in Call Option Activity - GuruFocus
Teladoc offers free non-emergency care for Texans impacted by winter storm - CW33.com
Analyst Calls: What is the target price for Teladoc Health Inc stockQuarterly Market Summary & Growth Focused Entry Point Reports - baoquankhu1.vn
Finanzdaten der Teladoc Health Inc-Aktie (TDOC)
Umsatz
Nettogewinn
Free Cashflow
ENV
16.55%
1.83%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):